Advertisement

Physician's First Watch

Physician's First Watch

Medical news from NEJM Journal Watch

July 25, 2014

By Kelly Young

Edited by William E. Chavey, MD, MS

Prenatal dalteparin does not reduce the incidence of pregnancy loss, placenta-mediated pregnancy complications, or venous thromboembolism among high-risk women with thrombophilia, according to an open-label trial...

Comments (0)

By Amy Orciari Herman

Edited by William E. Chavey, MD, MS

Rates of vaccination against human papillomavirus increased modestly among adolescents from 2012 to 2013, but missed opportunities for vaccination persisted, according to an MMWR article.

Analyzing data from...

Comments (0)

By Kristin J. Kelley

The FDA has approved a new abuse-deterrent treatment for severe pain — oxycodone hydrochloride and naloxone hydrochloride extended-release tablets marketed as Targiniq ER.

Approval was based on data from a clinical trial of...

Comments (0)

By Amy Orciari Herman

Edited by William E. Chavey, MD, MS

Patients with diabetes might face nearly a 50% increased risk for head and neck cancers, according to a retrospective, case-control study in JAMA Otolaryngology—Head

Comments (0)

July 24, 2014

By Joe Elia

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Despite being widely recommended as a first-line intervention in low-back pain, acetaminophen does no better than placebo, according to a Lancet study.

Some 1650...

Comments (3)

By the Editors

The FDA on Wednesday approved idelalisib (Zydelig) to treat patients with relapses of three...

Comments (0)

By Larry Husten

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Relying on new evidence along with previously disclosed data, an investigation in the BMJ casts doubt on the reliability of data supporting the anticoagulant dabigatran (Pradaxa).

The...

Comments (1)

By Kelly Young

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM

Having pregnancies in quick succession was not associated with increased risk for adverse birth outcomes in a study in the...

Comments (0)

Pages